Fundraising Fox
orvida
1 known investors
Find your way into orvida
Sign up to see every warm intro you have to orvida
- Paths you didn't know you had: your email and LinkedIn already hold routes to the orvida team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Orvida Pharma develops pharmaceuticals for rare genetic skin diseases and orphan indications, with expertise spanning drug development from early discovery through FDA and EMA regulatory approval.
Founders & leadership
DA
David AviezerCEODavid Aviezer holds a Ph.D. in Biochemistry & Molecular Biology from the Weizmann Institute of Science and an MBA from Bar Ilan University. He spent over 25 years in biotechnology, including 12 years as President & CEO of Protalix Biotherapeutics, where he oversaw FDA approval of Elelyso for Gaucher Disease and a NYSE listing, and now leads Orvida Pharma in developing therapeutics for rare genetic skin diseases.
LB
Liora BraimanPhD
Investors · 1
Frequently asked questions
- What does orvida do?
- Orvida Pharma develops pharmaceuticals for rare genetic skin diseases and orphan indications, with expertise spanning drug development from early discovery through FDA and EMA regulatory approval.
- Who are orvida's investors?
- orvida's investors include BRM Capital.